Ophthalmic Drugs Market Key Vendors, Segment, Growth Opportunities by 2024 to 2034
The Ophthalmic Drugs Market focuses on medications used to treat eye-related conditions and disorders. This market has been growing due to the increasing prevalence of eye diseases, aging populations, and advancements in drug delivery systems. The Ophthalmic Drugs market is projected to rise at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2034, when it is anticipated to reach USD 69.04 billion, based on an average growth pattern. The market is expected to be valued USD 41.19 billion in 2024. Ophthalmic medicines are medications created especially to treat conditions affecting the eyes. They come in a variety of forms, such as eye drops, ointments, and injectables. Many applications exist for these drugs, including the treatment of infections (antibiotics, for example), the reduction of inflammation (steroids, for example), the management of age-related macular degeneration (anti-VEGF drugs), the relief of allergy and dry eye symptoms, and the control of glauco...